Cargando…

An RBD virus-like particle vaccine for SARS-CoV-2 induces cross-variant antibody responses in mice and macaques

Detalles Bibliográficos
Autores principales: Li, Yuanyuan, Zhang, Yanan, Zhou, Yu, Li, Yan, Xu, Jiao, Ai, Yuanbao, Xu, Lei, Xiao, Xiuli, Zhang, Bo, Jin, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147897/
https://www.ncbi.nlm.nih.gov/pubmed/37120453
http://dx.doi.org/10.1038/s41392-023-01425-4
_version_ 1785034880902496256
author Li, Yuanyuan
Zhang, Yanan
Zhou, Yu
Li, Yan
Xu, Jiao
Ai, Yuanbao
Xu, Lei
Xiao, Xiuli
Zhang, Bo
Jin, Jing
author_facet Li, Yuanyuan
Zhang, Yanan
Zhou, Yu
Li, Yan
Xu, Jiao
Ai, Yuanbao
Xu, Lei
Xiao, Xiuli
Zhang, Bo
Jin, Jing
author_sort Li, Yuanyuan
collection PubMed
description
format Online
Article
Text
id pubmed-10147897
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-101478972023-05-01 An RBD virus-like particle vaccine for SARS-CoV-2 induces cross-variant antibody responses in mice and macaques Li, Yuanyuan Zhang, Yanan Zhou, Yu Li, Yan Xu, Jiao Ai, Yuanbao Xu, Lei Xiao, Xiuli Zhang, Bo Jin, Jing Signal Transduct Target Ther Letter Nature Publishing Group UK 2023-04-29 /pmc/articles/PMC10147897/ /pubmed/37120453 http://dx.doi.org/10.1038/s41392-023-01425-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Li, Yuanyuan
Zhang, Yanan
Zhou, Yu
Li, Yan
Xu, Jiao
Ai, Yuanbao
Xu, Lei
Xiao, Xiuli
Zhang, Bo
Jin, Jing
An RBD virus-like particle vaccine for SARS-CoV-2 induces cross-variant antibody responses in mice and macaques
title An RBD virus-like particle vaccine for SARS-CoV-2 induces cross-variant antibody responses in mice and macaques
title_full An RBD virus-like particle vaccine for SARS-CoV-2 induces cross-variant antibody responses in mice and macaques
title_fullStr An RBD virus-like particle vaccine for SARS-CoV-2 induces cross-variant antibody responses in mice and macaques
title_full_unstemmed An RBD virus-like particle vaccine for SARS-CoV-2 induces cross-variant antibody responses in mice and macaques
title_short An RBD virus-like particle vaccine for SARS-CoV-2 induces cross-variant antibody responses in mice and macaques
title_sort rbd virus-like particle vaccine for sars-cov-2 induces cross-variant antibody responses in mice and macaques
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147897/
https://www.ncbi.nlm.nih.gov/pubmed/37120453
http://dx.doi.org/10.1038/s41392-023-01425-4
work_keys_str_mv AT liyuanyuan anrbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT zhangyanan anrbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT zhouyu anrbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT liyan anrbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT xujiao anrbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT aiyuanbao anrbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT xulei anrbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT xiaoxiuli anrbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT zhangbo anrbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT jinjing anrbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT liyuanyuan rbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT zhangyanan rbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT zhouyu rbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT liyan rbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT xujiao rbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT aiyuanbao rbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT xulei rbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT xiaoxiuli rbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT zhangbo rbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques
AT jinjing rbdviruslikeparticlevaccineforsarscov2inducescrossvariantantibodyresponsesinmiceandmacaques